85 related articles for article (PubMed ID: 34386936)
1. Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder.
Jaggi A; Nazir J; Fatoye F; Quelen C; Tu X; Ali M; Siddiqui E; Covernton PJO; Landeira M; Choudhury N
Drugs Aging; 2021 Oct; 38(10):911-920. PubMed ID: 34386936
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study.
Ivchenko A; Bödeker RH; Neumeister C; Wiedemann A
BMC Urol; 2018 Sep; 18(1):80. PubMed ID: 30217174
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder.
Araklitis G; Robinson D; Cardozo L
Clin Interv Aging; 2020; 15():1493-1503. PubMed ID: 32921995
[TBL] [Abstract][Full Text] [Related]
4. Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions.
Rutman MP; Horn JR; Newman DK; Stefanacci RG
Clin Drug Investig; 2021 Apr; 41(4):293-302. PubMed ID: 33713027
[TBL] [Abstract][Full Text] [Related]
5. Despite Recommendations, Anticholinergics Account for the Majority of Prescriptions to Treat Overactive Bladder in the United States.
Carr DN; Macharia A; Hacker MR; Winkelman WD
Urogynecology (Phila); 2023 May; 29(5):497-503. PubMed ID: 36730660
[TBL] [Abstract][Full Text] [Related]
6. Disentangling drug contributions: anticholinergic burden in older adults linked to individual medications: a cross-sectional population-based study.
Bhatkhande G; Choudhry NK; Mahesri M; Haff N; Lauffenburger JC
BMC Geriatr; 2024 Jan; 24(1):44. PubMed ID: 38200457
[TBL] [Abstract][Full Text] [Related]
7. The effect of the anticholinergic burden on mortality following elective cardiac surgery.
Katipoglu B; Kurtbeyoglu S; Demir ZA; Mavioglu HL
Curr Med Res Opin; 2024 Jan; 40(1):27-34. PubMed ID: 37999982
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic Burden Does Not Influence Delirium Subtype or the Delirium-Mortality Association in Hospitalized Older Adults: Results from a Prospective Cohort Study.
Rawle MJ; McCue L; Sampson EL; Davis D; Vickerstaff V
Drugs Aging; 2021 Mar; 38(3):233-242. PubMed ID: 33415708
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic drugs and risk of dementia: Time for action?
Bell B; Avery A; Bishara D; Coupland C; Ashcroft D; Orrell M
Pharmacol Res Perspect; 2021 May; 9(3):e00793. PubMed ID: 34087056
[TBL] [Abstract][Full Text] [Related]
10. Polypharmacy, drug-drug interactions, anticholinergic burden and cognitive outcomes: a snapshot from a community-dwelling sample of older men and women in northern Italy.
Perdixi E; Cotta Ramusino M; Costa A; Bernini S; Conti S; Jesuthasan N; Severgnini M; Prinelli F;
Eur J Ageing; 2024 Mar; 21(1):11. PubMed ID: 38551689
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impact of anticholinergic and sedative burden in people living with HIV.
Michael HU; Brouillette MJ; Tamblyn R; Fellows LK; Mayo NE
AIDS; 2024 Jun; ():. PubMed ID: 38905493
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Impact of Overactive Bladder Medications on Cognition.
Vargas Maldonado D; Schulte PJ; Latuche LR; Vassilaki M; Petersen RC; Occhino JA; Linder BJ
Urogynecology (Phila); 2024 May; ():. PubMed ID: 38710025
[TBL] [Abstract][Full Text] [Related]
13. Exploring the impact of anticholinergic burden on urinary independence: insights from a post-stroke cohort of older adults.
Matsumoto A; Yoshimura Y; Nagano F; Shimazu S; Shiraishi A; Kido Y; Bise T; Kuzuhara A; Hori K; Hamada T; Yoneda K; Maekawa K
Int J Clin Pharm; 2024 Apr; ():. PubMed ID: 38635116
[TBL] [Abstract][Full Text] [Related]
14. Assessing the anticholinergic cognitive burden classification of putative anticholinergic drugs using drug properties.
Phutietsile GO; Fotaki N; Nishtala PS
Br J Clin Pharmacol; 2024 Jun; ():. PubMed ID: 38863280
[TBL] [Abstract][Full Text] [Related]
15. Increase in anticholinergic burden from 1990 to 2015: Age-period-cohort analysis in UK biobank.
Mur J; Cox SR; Marioni RE; Muniz-Terrera G; Russ TC
Br J Clin Pharmacol; 2022 Mar; 88(3):983-993. PubMed ID: 34409635
[TBL] [Abstract][Full Text] [Related]
16. Vibegron: a β
Paton DM
Drugs Today (Barc); 2021 Aug; 57(8):507-517. PubMed ID: 34405208
[TBL] [Abstract][Full Text] [Related]
17. Management of urinary incontinence following treatment of prostate disease.
Clark CB; Kucherov V; Klonieck E; Shenot PJ; Das AK
Can J Urol; 2021 Aug; 28(S2):38-43. PubMed ID: 34453428
[TBL] [Abstract][Full Text] [Related]
18. The cognitive effect of anticholinergics for patients with overactive bladder.
Welk B; Richardson K; Panicker JN
Nat Rev Urol; 2021 Nov; 18(11):686-700. PubMed ID: 34429535
[TBL] [Abstract][Full Text] [Related]
19. The use of mono- and combination drug therapy in men and women with lower urinary tract symptoms (LUTS) in the UK: a retrospective observational study.
Ali M; Landeira M; Covernton PJO; Choudhury N; Jaggi A; Fatoye F; van Maanen R
BMC Urol; 2021 Sep; 21(1):119. PubMed ID: 34474675
[TBL] [Abstract][Full Text] [Related]
20. The impact of anticholinergics on cognitive function in patients with neurogenic lower urinary tract dysfunction: A narrative review.
Welk B
Indian J Urol; 2024; 40(2):82-87. PubMed ID: 38725892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
